313 related articles for article (PubMed ID: 25566802)
41. APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces.
Salamango DJ; McCann JL; Demir Ö; Brown WL; Amaro RE; Harris RS
J Mol Biol; 2018 Aug; 430(17):2695-2708. PubMed ID: 29787764
[TBL] [Abstract][Full Text] [Related]
42. Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.
Nikkilä J; Kumar R; Campbell J; Brandsma I; Pemberton HN; Wallberg F; Nagy K; Scheer I; Vertessy BG; Serebrenik AA; Monni V; Harris RS; Pettitt SJ; Ashworth A; Lord CJ
Br J Cancer; 2017 Jun; 117(1):113-123. PubMed ID: 28535155
[TBL] [Abstract][Full Text] [Related]
43. Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.
Caval V; Bouzidi MS; Suspène R; Laude H; Dumargne MC; Bashamboo A; Krey T; Vartanian JP; Wain-Hobson S
Nucleic Acids Res; 2015 Oct; 43(19):9340-9. PubMed ID: 26384561
[TBL] [Abstract][Full Text] [Related]
44. Visualization of uracils created by APOBEC3A using UdgX shows colocalization with RPA at stalled replication forks.
Stewart JA; Schauer G; Bhagwat AS
Nucleic Acids Res; 2020 Nov; 48(20):e118. PubMed ID: 33074285
[TBL] [Abstract][Full Text] [Related]
45. Evidence for APOBEC3B mutagenesis in multiple human cancers.
Burns MB; Temiz NA; Harris RS
Nat Genet; 2013 Sep; 45(9):977-83. PubMed ID: 23852168
[TBL] [Abstract][Full Text] [Related]
46. PrimPol prevents APOBEC/AID family mediated DNA mutagenesis.
Pilzecker B; Buoninfante OA; Pritchard C; Blomberg OS; Huijbers IJ; van den Berk PC; Jacobs H
Nucleic Acids Res; 2016 Jun; 44(10):4734-44. PubMed ID: 26926109
[TBL] [Abstract][Full Text] [Related]
47. Polyomavirus T Antigen Induces
Starrett GJ; Serebrenik AA; Roelofs PA; McCann JL; Verhalen B; Jarvis MC; Stewart TA; Law EK; Krupp A; Jiang M; Martens JWM; Cahir-McFarland E; Span PN; Harris RS
mBio; 2019 Feb; 10(1):. PubMed ID: 30723127
[TBL] [Abstract][Full Text] [Related]
48. Monitoring APOBEC3A protein levels in human cancer cells.
Dananberg A; Maciejowski J
Methods Cell Biol; 2024; 182():313-327. PubMed ID: 38359985
[TBL] [Abstract][Full Text] [Related]
49. APOBEC3B is preferentially expressed at the G2/M phase of cell cycle.
Hirabayashi S; Shirakawa K; Horisawa Y; Matsumoto T; Matsui H; Yamazaki H; Sarca AD; Kazuma Y; Nomura R; Konishi Y; Takeuchi S; Stanford E; Kawaji H; Murakawa Y; Takaori-Kondo A
Biochem Biophys Res Commun; 2021 Mar; 546():178-184. PubMed ID: 33592502
[TBL] [Abstract][Full Text] [Related]
50. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
Nowarski R; Kotler M
Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
[TBL] [Abstract][Full Text] [Related]
51. Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB.
Periyasamy M; Singh AK; Gemma C; Farzan R; Allsopp RC; Shaw JA; Charmsaz S; Young LS; Cunnea P; Coombes RC; Győrffy B; Buluwela L; Ali S
Oncogene; 2021 Feb; 40(6):1077-1090. PubMed ID: 33323971
[TBL] [Abstract][Full Text] [Related]
52. DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.
Fu Y; Ito F; Zhang G; Fernandez B; Yang H; Chen XS
Biochem J; 2015 Oct; 471(1):25-35. PubMed ID: 26195824
[TBL] [Abstract][Full Text] [Related]
53. APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistance.
Schmitt C; Lucius R; Synowitz M; Held-Feindt J; Hattermann K
Oncol Rep; 2018 Nov; 40(5):2742-2749. PubMed ID: 30226610
[TBL] [Abstract][Full Text] [Related]
54. Involvement of APOBEC3B in mutation induction by irradiation.
Saito Y; Miura H; Takahashi N; Kuwahara Y; Yamamoto Y; Fukumoto M; Yamamoto F
J Radiat Res; 2020 Nov; 61(6):819-827. PubMed ID: 32880638
[TBL] [Abstract][Full Text] [Related]
55. Genetic inhibitors of APOBEC3B-induced mutagenesis.
Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Cordero C; Bray N; Harcy V; Vyas RK; Mitchell D; Lobachev K; Roberts SA
Genome Res; 2023 Sep; 33(9):1568-1581. PubMed ID: 37532520
[TBL] [Abstract][Full Text] [Related]
56. Error-free versus mutagenic processing of genomic uracil--relevance to cancer.
Krokan HE; Sætrom P; Aas PA; Pettersen HS; Kavli B; Slupphaug G
DNA Repair (Amst); 2014 Jul; 19():38-47. PubMed ID: 24746924
[TBL] [Abstract][Full Text] [Related]
57. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
[TBL] [Abstract][Full Text] [Related]
58. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.
Wang S; Jia M; He Z; Liu XS
Oncogene; 2018 Jul; 37(29):3924-3936. PubMed ID: 29695832
[TBL] [Abstract][Full Text] [Related]
59. Primary mucosal melanomas of the head and neck are characterised by overexpression of the DNA mutating enzyme APOBEC3B.
Argyris PP; Naumann J; Jarvis MC; Wilkinson PE; Ho DP; Islam MN; Bhattacharyya I; Gopalakrishnan R; Li F; Koutlas IG; Giubellino A; Harris RS
Histopathology; 2023 Mar; 82(4):608-621. PubMed ID: 36416305
[TBL] [Abstract][Full Text] [Related]
60. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
